术前渐进性气腹联合A型肉毒毒素用于腹壁缺损疝的观察研究
该观察性研究纳入70例腹壁缺损疝(LODH)患者,在术前联合应用渐进性气腹(PPP)与A型肉毒毒素(BT),并用腹部CT测量疝囊、腹壁缺损(VIH)与腹腔(VAC)体积及VIH/VAC比值。结果显示联合准备后VIH/VAC比值平均下降16.6%(p<0.05),疝复发4例(5.7%)。
要点
- PPP联合BT可降低VIH/VAC比值,为LODH关腹创造条件。
- PPP相关并发症发生率20%,BT给药期间无并发症。
- 术后中位随访34.5±22.3个月,疝复发4例(5.7%)。
核心结论
- 采用CT体积测量方案,PPP联合BT可降低VIH/VAC比值和疝缺损直径,是LODH治疗的关键因素。
研究设计与样本
- 2010年5月至2016年5月连续纳入70例腹壁缺损疝(LODH)患者的观察性研究。
- 在PPP和BT前后用腹部CT数据测量疝囊、腹壁缺损(VIH)与腹腔(VAC)体积及VIH/VAC比值。
- VIH/VAC比值>20%时联合应用PPP与BT两种术前准备技术。
主要发现
- PPP中位注气量为8450±3400 cc(4500-13450),持续11.3±2.3天(9-16)。
- BT给药时间为38.1±3.7天(35-44)。
- PPP联合BT后VIH/VAC比值平均下降16.6%(p<0.05)。
- PPP相关并发症为20%,手术技术相关并发症为29.6%,BT给药期间无并发症。
- 重建技术为前入路组织结构分离(CST)54例、TAR 14例、Rives-Stoppa 2例。
关键数值与推荐
- 联合应用PPP与BT的指征为VIH/VAC比值>20%。
- PPP注气量8450±3400 cc(4500-13450),持续11.3±2.3天(9-16)。
- BT给药时间38.1±3.7天(35-44)。
临床怎么用
- 对VIH/VAC比值>20%的LODH患者,可考虑术前PPP联合BT以降低比值和缺损直径。
- 术前应采用CT体积测量方案评估疝囊、腹腔体积及VIH/VAC比值变化。
- 需向患者告知PPP相关并发症(20%)与手术技术相关并发症(29.6%)风险。
局限性
- 为单中心观察性研究,无对照组,样本量70例。
- 随访时间中位34.5±22.3个月,复发4例(5.7%),长期复发情况需进一步观察。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Preoperative progressive pneumoperitoneum (PPP) and botulinum toxin type A (BT) are tools in the surgical preparation of patients with loss of domain hernias (LODH). The aim of this paper is to report our experience with these preoperative techniques in 70 patients with LODH. METHODS: Observational study of 70 consecutive patients with LODH was conducted between May 2010 and May 2016. Diameters of the hernia sac, incisional hernia (VIH), and abdominal cavity (VAC) volumes, and VIH/VAC ratio were measured before and after PPP and BT, using abdominal CT scan data. Combination of both techniques was performed when the VIH/VAC ratio was > 20%. RESULTS: Median insufflated volume of air for PPP was 8450 ± 3400 cc (4500-13,450), over a period of 11.3 ± 2.3 days (9-16). BT administration time was 38.1 ± 3.7 days (35-44). An average reduction of 16.6% of the VIH/VAC ratio after PPP and BT was obtained (p < 0.05). Complications associated with PPP were 20%, and with surgical technique 29.6%. No complications occurred during the BT administration. Reconstructive technique was anterior CST in 54 patients, TAR in 14 cases and Rives-Stoppa technique in two patients. Median follow-up was 34.5 ± 22.3 months (12-60) and four cases of hernia recurrence (5.7%) were reported. CONCLUSIONS: Using a CT volumetric protocol, combination of PPP and BT decreases the VIH/VAC ratio and hernia defect diameters, which constitutes a key factor in the treatment of LODH.
引用
- Bueno-Lledó J, Torregrosa A, Jiménez R, et al. Preoperative combination of progressive pneumoperitoneum and botulinum toxin type A in patients with loss of domain hernia. Surg Endosc. 2018. PMID: 29450631. doi:10.1007/s00464-018-6089-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。